Snoring is a common presenting complaint to otorhinolaryngologists. NICE guidelines (May 2005)1 suggest radiofrequency ablation as a treatment for snoring, which is unavailable in some NHS trusts.
The oral device commonly used for problematic snoring is the Mandibular Advancement Device (MAD). Patient compliance and results with these devices vary.
A relatively new device, the Tongue Stabilising Device (TSD) is used in some centres/trusts. The objective was to audit against an identified compliance standard of 55%2 with the MAD for the TSD.
Patients referred to ENT outpatient clinic with problematic snoring and no OSA, who voluntarily accepted to use the TSD were invited to partake. The outcome measures were the Percentage compliance, and ESS and PSQI scores in compliant patients.